ential RP Treatment Based on Ancient Chinese Medicine
The Foundation Fighting Blindness is working toward launching a clinical trial in 2011 of a vision-preserving agent known as TUDCA. Based on a traditional Chinese medicine, TUDCA is a synthetically manufactured bile acid that has demonstrated safety and efficacy in animal models of retinal degeneration. Foundation-funded animal studies are taking place at the Oregon Health & Science University to determine optimal TUDCA dosing for humans.
The TUDCA clinical trial would likely take place in the Foundation’s National Eye Evaluation and Research Network and include people with both recessive and dominant forms of retinitis pigmentosa. Researchers note that TUDCA may also benefit people with other retinal degenerative diseases, but more studies are needed to determine who might benefit from the agent.
刚看到一则电子邮件消息，大概意思是说抗盲基金会创立的一个研究组织吧实验一种以传统中药为基础的tudca能够有效用于动物RP模体上。现在正以配量的方式将用于人体试验上。进行研究地点是俄勒冈州健康和科学大学，研究对象是显性和隐性rp。研究人员发现这药同样有效于其他的视网膜疾病。
内容比较简短，希望其他病友可找到更详细完整的信息。 |
